Fever News and Research

RSS

Use of anti-inflammatory drugs by children may be associated with dental enamel defects

A study conducted at the University of São Paulo in Brazil and described in an article published in the journal Scientific Reports shows that anti-inflammatory drugs commonly taken by children may be associated with dental enamel defects (DEDs), currently seen in about 20% of children worldwide.

20 Dec 2022

Trial of three vaccines for Zaire Ebola virus disease

Researchers perform two randomized controlled trials to determine immunogenicity and safety of three Ebola vaccines.

20 Dec 2022

Can ivermectin improve the duration of sustained recovery among COVID-19 outpatients?

Researchers assessed the impact of ivermectin on the duration of sustained recovery among coronavirus disease 2019 (COVID-19) outpatients.

20 Dec 2022

Active transmission of Bourbon virus in New York

A recent study published in Emerging Infectious Diseases reported on the bourbon virus (BRBV) transmission in New York.

20 Dec 2022

Inside a children’s hospital: Struggling to cope with a surge of respiratory illness

Waiting for their turn in the emergency room, dazed-looking parents in winter coats bounced crying children in their arms, trying to catch the eye of Dr. Erica Michiels. Us! Pick us next! they seemed to plead with tired eyes.

20 Dec 2022

Milk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infection

Researchers longitudinally evaluated the antibody response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in lactating individuals.

19 Dec 2022

Recent surge in group A streptococcal infections among children in UK

In an editorial published in the journal New Microbes and New Infections, scientists have highlighted the possible reasons behind a sudden rise in cases of group A streptococcal infections among children in the United Kingdom and other European countries.

18 Dec 2022

Novel immunotherapy offers a promising new strategy to fight hard-to-treat cancers

Scientists at UC San Francisco have engineered T cells to produce a potent anti-cancer cytokine, but only when they encounter tumor cells.

16 Dec 2022

Trial results confirm the safety of three different Ebola vaccine regimens

Ebola epidemics occur periodically in various sub-Saharan African countries. While vaccines exist and have already received WHO Prequalification against the Zaire ebolavirus species, it is essential to pursue and intensify efforts to supplement the available data to develop a safe and effective Ebola vaccine strategies in adults and children alike.

16 Dec 2022

Natural substances show great therapeutic potential to inhibit influenza viruses

Fever, cough, sore throat, and general malaise - the cold season is here, and not only corona but also influenza viruses are spreading again at a rapid pace.

16 Dec 2022

How do predicted ecological niches of the mpox virus compare with that of 99 mammal species?

Researchers compared ecological niches to identify probable mpox virus reservoir hosts.

15 Dec 2022

Influenza vaccine effectiveness during the 2021–2022 influenza season in the United States

Researchers estimated influenza VE in patients aged ≥6 months seeking outpatient care for ARI due to the influenza A(H3N2) virus between October 2021 and April 2022 in the United States (US).

15 Dec 2022

AI model provides a way for rapid COVID-19 testing and detection

COVID-19 and its latest Omicron strains continue to cause infections across the country as well as globally. Serology (blood) and molecular tests are the two most commonly used methods for rapid COVID-19 testing.

13 Dec 2022

Antibody discovery could explain why so many group A strep vaccines have failed

Researchers at Lund University in Sweden have discovered an antibody with the potential to protect against Strep A infection, as well as a rare form of antibody binding, that leads to an effective immune response against bacteria.

12 Dec 2022

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab-;a novel, patient-tailored monoclonal antibody therapy-;showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers reported in The Lancet.

12 Dec 2022

Knowledge and attitudes to mpox among GBMSM in Australia

Researchers presented the results of a cross-sectional survey done in Australia between August and September 2022.

12 Dec 2022

Off-the-shelf immunotherapy could offer new hope for patients with hard-to-treat multiple myeloma

A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

12 Dec 2022

Fever News and Research

Use of anti-inflammatory drugs by children may be associated with dental enamel defects

Trial of three vaccines for Zaire Ebola virus disease

Can ivermectin improve the duration of sustained recovery among COVID-19 outpatients?

Active transmission of Bourbon virus in New York

Inside a children’s hospital: Struggling to cope with a surge of respiratory illness

Milk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infection

Recent surge in group A streptococcal infections among children in UK

Novel immunotherapy offers a promising new strategy to fight hard-to-treat cancers

Trial results confirm the safety of three different Ebola vaccine regimens

Natural substances show great therapeutic potential to inhibit influenza viruses

How do predicted ecological niches of the mpox virus compare with that of 99 mammal species?

Influenza vaccine effectiveness during the 2021–2022 influenza season in the United States

AI model provides a way for rapid COVID-19 testing and detection

Antibody discovery could explain why so many group A strep vaccines have failed

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

Knowledge and attitudes to mpox among GBMSM in Australia

Off-the-shelf immunotherapy could offer new hope for patients with hard-to-treat multiple myeloma

Reports of Mpox disease following recent vaccination

Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

Researchers discover a previously unknown mechanism that drives aging

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News